Focus on ulcerative colitis: Stable gastric pentadecapeptide BPC 157

Current Medicinal Chemistry

Volumn 19, Issue 1, 2012, Pages 126-132

  Sikiric, P ^a   Seiwerth, S ^a   Rucman, R ^a   Turkovic, B ^a   S Rokotov, D ^a   Brcic, L ^a   Sever, M ^a   Klicek, R ^a   Radic, B ^a   Drmic, D ^a   Ilic, S ^a   Kolenc, D ^a   Stambolija, V ^a   Zoricic, Z ^a   Vrcic, H ^a   Sebecic, B ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

BPC 157; Colocutaneous fistulas; Inflammatory bowel disease; Intestinal anastomosis; Short bowel

Indexed keywords

ANTIULCER AGENT; COLLAGEN; EARLY GROWTH RESPONSE FACTOR 1; LEUKOTRIENE B4; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTADECAPEPTIDE BPC 157; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANASTOMOSIS; ANTIULCER ACTIVITY; ARTICLE; BLOOD CLOTTING; COLOCUTANEOUS FISTULA; COLON FISTULA; GENE EXPRESSION; INTESTINE ULCER; NONHUMAN; STOMACH JUICE; STOMACH ULCER; ULCERATIVE COLITIS; WOUND HEALING;

EID: 84857510781     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803414015     Document Type: Article

References (64)

1. Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Vrcic H, Sebecic B. Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Curr Pharm Des. 2011; 17: 1612-1632.
2. Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101:706-712.
3. Morrison G, Headon B, Gibson P. Update in inflammatory bowel disease. Aust Fam Physician. 2009;38:956-961.
4. Fiorino G, Rovida S, Correale C, Malesci A, Danese S. Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? Curr Drug Targets. 2010;11:249-60.
5. Sikiric P, Seiwerth S, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D. Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr Pharm Des. 2010;16:1224-1234.
6. Tkalceviń VI, Cuziń S, Brajsa K, Mildner B, Bokuliń A, Situm K, Peroviń D, Glojnariń I, Parnham MJ. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression.Eur J Pharmacol. 2007;570:212-221. (Pubitemid 47247673)
7. Bilic M, Bumber Z, Blagaic AB, Batelja L, Seiwerth S, Sikiric P. The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice.Burns. 2005;31:310-315
8. Sikiric P, Seiwerth S, Mise S, Staresinic M, Bedekovic V, Zarkovic N, Borovic S, Gjurasin M, Boban-Blagaic A, Batelja L, Rucman R, Anic T. Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice.Burns. 2003;29:323-334. (Pubitemid 36627674)
9. Mikus D, Sikiric P, Seiwerth S, Petricevic A, Aralica G, Druzijancic N, Rucman R, Petek M, Pigac B, Perovic D, Kolombo M, Kokic N, Mikus S, Duplancic B, Fattorini I, Turkovic B, Rotkvic I, Mise S, Prkacin I, Konjevoda P, Stambuk N, Anic T. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice.Burns. 2001;27:817-827.
10. Balenovic D, Bencic ML, Udovicic M, Simonji K, Hanzevacki JS, Barisic I, Kranjcevic S, Prkacin I, Coric V, Brcic L, Coric M, Brcic I, Borovic S, Radic B, Drmic D, Vrcic H, Seiwerth S, Sikiric P.Inhibition of methyldigoxininduced arrhythmias by pentadecapeptide BPC 157: a relation with NOsystem. Regul Pept. 2009;156:83-89.
11. Klicek R, Sever M, Radic B, Drmic D, Kocman I, Zoricic I, Vuksic T, Ivica M, Barisic I, Ilic S, Berkopic L, Vrcic H, Brcic L, Blagaic AB, Coric M, Brcic I, Rokotov DS, Anic T, Seiwerth S, Sikiric P.Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.J Pharmacol Sci. 2008;108:7-17.
12. Boban-Blagaic A, Blagaic V, Romic Z, Jelovac N, Dodig G, Rucman R, Petek M, Turkovic B, Seiwerth S, Sikiric P.The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-L-arginine methyl ester and L-arginine.Med Sci Monit. 2006;12:BR36-45. (Pubitemid 43116651)
13. Sikiriń P, Seiwerth S, Grabareviń Z, Rucman R, Petek M, Jagiń V, Turkoviń B, Rotkviń I, Mise S, Zoriciń I, Konjevoda P, Peroviń D, Jurina L, Separoviń J, Hanzevacki M, Artukoviń B, Bratuliń M, Tisljar M, Gjurasin M, Mikliń P, Stanciń-Rokotov D, Slobodnjak Z, Jelovac N, Maroviń A.The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol. 1997;332:23-33. (Pubitemid 27346600)
14. Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, Sikiric P, Peric J, Geres D, Kos J. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks.J Physiol Paris. 1997;91:139-149. (Pubitemid 27467018)
15. Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V, Aralica G, Konjevoda P, Batelja L, Blagaic AB. Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse.J Pharmacol Sci. 2004;95:19-26 (Pubitemid 38856041)
16. Hrelec M, Klicek R, Brcic L, Brcic I, Cvjetko I, Seiwerth S, Sikiric P. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy.J Physiol Pharmacol. 2009;60 Suppl 7:161-5.
17. Ilic S, Brcic I, Mester M, Filipovic M, Sever M, Klicek R, Barisic I, Radic B, Zoricic Z, Bilic V, Berkopic L, Brcic L, Kolenc D, Romic Z, Pazanin L, Seiwerth S, Sikiric P. Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats.J Physiol Pharmacol. 2009;60 Suppl 7:107-114.
18. Sikiric P. The pharmacological properties of the novel peptide BPC 157 (PL-10). Inflammopharmacology. 1999;7:1-14. (Pubitemid 29274787)
19. Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K, Jakir A, Udovicic M, Tonkic A, Kokic N, Turkovic B, Mise S, Anic T. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. Inflammopharmacology. 2006;14:214-221. (Pubitemid 46025537)
20. Sikiric P, Separovic J, Anic T, Buljat G, Mikus D, Seiwerth S, Grabarevic Z, Stancic-Rokotov D, Pigac B, Hanzevacki M, Marovic A, Rucman R, Petek M, Zoricic I, Ziger T, Aralica G, Konjevoda P, Prkacin I, Gjurasin M, Miklic P, Artukovic B, Tisljar M, Bratulic M, Mise S, Rotkvic I. The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation. J Physiol Paris. 1999;93:479-485 (Pubitemid 30038581)
21. Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009;60 Suppl 7:191-196.
22. Sikiric P, Seiwerth S, Grabarevic Z, Petek M, Rucman R, Turkovic B, Rotkvic I, Jagic V, Duvnjak M, Mise S. The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sci. 1994;54:PL63-68.
23. Cerovecki T, Bojanic I, Brcic L, Radic B, Vukoja I, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthopaed Res. 2010;28:1155-1161.
24. Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T, Sever M, Kocijan A, Berkopic L, Radic B, Buljat G, Anic T, Zoricic I, Bojanic I, Seiwerth S, Sikiric P. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010;16:BR81-88.
25. Novinscak T, Brcic L, Staresinic M, Jukic I, Radic B, Pevec D, Mise S, Tomasovic S, Brcic I, Banic T, Jakir A, Buljat G, Anic T, Zoricic I, Romic Z, Seiwerth S, Sikiric P. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.Surg Today. 2008;38:716-725.
26. Krivic A, Majerovic M, Jelic I, Seiwerth S, Sikiric P.Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157 and methylprednisolone. Inflamm Res. 2008;57:205-210. (Pubitemid 351929676)
27. Staresinic M, Petrovic I, Novinscak T, Jukic I, Pevec D, Suknaic S, Kokic N, Batelja L, Brcic L, Boban-Blagaic A, Zoric Z, Ivanovic D, Ajduk M, Sebecic B, Patrlj L, Sosa T, Buljat G, Anic T, Seiwerth S, Sikiric P. Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157.J Orthop Res. 2006;24:1109-1117. (Pubitemid 43804947)
28. Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation.J Orthopaed Res. 2006;24:982-989. (Pubitemid 43804933)
29. Staresinic M, Sebecic B, Patrlj L, Jadrijevic S, Suknaic S, Perovic D, Aralica G, Zarkovic N, Borovic S, Srdjak M, Hajdarevic K, Kopljar M, Batelja L, Boban-Blagaic A, Turcic I, Anic T, Seiwerth S, Sikiric P. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.J Orthop Res. 2003;21:976-983. (Pubitemid 37322377)
30. Krivic A, Sikiric P.Comment on "Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel". Am J Sports Med. 2003;31:636-637.
31. Vuksic T, Zoricic I, Brcic L, Sever M, Klicek R, Radic B, Cesarec V, Berkopic L, Keller N, Blagaic AB, Kokic N, Jelic I, Geber J, Anic T, Seiwerth S, Sikiric P. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat. Surg Today. 2007;37:768-777. (Pubitemid 47312514)
32. Sever M, Klicek R, Radic B, Brcic L, Zoricic I, Drmic D, Ivica M, Barisic I, Ilic S, Berkopic L, Blagaic AB, Coric M, Kolenc D, Vrcic H, Anic T, Seiwerth S, Sikiric P.Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.Dig Dis Sci. 2009;54:2070-2083.
33. Veljaca M, Lesch CA, Sanchez B, Low J, Guglietta A. Protection of BPC-15 on TNBS-induced colitis in rats: possible mechanisms of action. Gastroenterology. 1995;108:936.
34. Veljaca M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglietta A. BPC-15 reduces trinitrobenzene sulfonic acid-inducedcolonic damage in rats. J Pharmacol Exp Ther. 1994;272:417-422.
35. Orsolic N, Seiwerth S, Sikiric P. BPC 157 enhances function of immunological effector cells in mice. J Physiol Pharmacol. 2009; 60 Suppl2:69.
36. Sikiric P, Seiwerth S, Aralica G, Perovic D, Staresinic M, Anic T, Gjurasin M, Prkacin I, Separovic J, Stancic-Rokotov D, Lovric-Bencic M, Mikus D, Turkovic B, Rotkvic I, Mise S, Rucman R, Petek M, Ziger T, Sebecic B, Ivasovic Z, Jagic V, Komericki L, Balen I, Boban-Blagaic A, Sjekavica I. Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat.J Physiol Paris. 2001;95:283-288. (Pubitemid 33020251)
37. Sikiric P, Seiwerth S, Grabarevic Z, Balen I, Aralica G, Gjurasin M, Komericki L, Perovic D, Ziger T, Anic T, Prkacin I, Separovic J, Stancic-Rokotov D, Lovric-Bencic M, Mikus D, Staresinic M, Aralica J, DiBiaggio N, Simec Z, Turkovic B, Rotkvic I, Mise S, Rucman R, Petek M, Sebecic B, Ivasovic Z, Boban-Blagaic A, Sjekavica I. Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone.J Physiol Paris. 2001;95:261-270. (Pubitemid 33020248)
38. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 2009;104:1298-313;.
39. Sikiriń P, Seiwerth S, Grabareviń Z, Rucman R, Petek M, Jagiń V, Turkoviń B, Rotkviń I, Mise S, Zoriciń I, Gjurasin M, Konjevoda P, Separoviń J, Ljubanoviń D, Artukoviń B, Bratuliń M, Tisljar M, Jurina L, Buljat G, Mikliń P, Maroviń A. Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity. Dig Dis Sci. 1996;41:1604-14.
40. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Konjevoda P, Perovic D, Simicevic V, Separovic J, Hanzevacki M, Ljubanovic D, Artukovic B, Bratulic M, Tisljar M, Rekic B, Gjurasin M, Miklic P, Buljat G. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats. J Physiol Paris. 1997;91:113-122. (Pubitemid 27467014)
41. Ilic S, Drmic D, Zarkovic K, Kolenc D, Coric M, Brcic L, Klicek R, Radic B, Sever M, Djuzel V, Ivica M, Boban Blagaic A, Zoricic Z, Anic T, Zoricic I, Djidic S, Romic Z, Seiwerth S, Sikiric P. High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736).J Physiol Pharmacol. 2010;61:241-250.
42. Ilic S, Drmic D, Franjic S, Kolenc D, Coric M, Brcic L, Klicek R, Radic B, Sever M, Djuzel V, Filipovic M, Djakovic Z, Stambolija V, Blagaic AB, Zoricic I, Gjurasin M, Stupnisek M, Romic Z, Zarkovic K, Dzidic S, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life Sci. 2011;88:535-42.
43. Ilic S, Drmic D, Zarkovic K, Kolenc D, Brcic L, Radic B, Djuzel V, Boban Blagaic A, Romic Z, Dzidic S, Kalogjera L, Seiwerth S, and Sikiric P. Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. Eur J Pharmacol. 2011; 667:322-329.
44. Urist MR. The first three decades of bone morphogenetic protein. Osteologie. 1996;4:207-233.
45. Dobric I, Drvis P, Petrovic I, Shejbal D, Brcic L, Blagaic AB, Batelja L, Sever M, Kokic N, Tonkic A, Zoricic I, Mise S, Staresinic M, Radic B, Jakir A, Babel J, Ilic S, Vuksic T, Jelic I, Anic T, Seiwerth S, Sikiric P. Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157. J Pharmacol Sci. 2007;104:7-18. (Pubitemid 46790311)
46. Petrovic I, Dobric I, Drvis P, Shejbal D, Brcic L, Blagaic AB, Batelja L, Kokic N, Tonkic A, Mise S, Baotic T, Staresinic M, Radic B, Jakir A, Vuksic T, Anic T, Seiwerth S, Sikiric P. An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157.J Pharmacol Sci. 2006;102:269-277. (Pubitemid 44790688)
47. Sebecic B, Nikolic V, Sikiric P, Seiwerth S, Sosa T, Patrlj L, Grabareviń Z, Rucman R, Petek M, Konjevoda P, Jadrijeviń S, Peroviń D, Slaj M. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone. 1999;24:195-202. (Pubitemid 29094561)
48. Keremi B, Lohinai Z, Komora P, Duhaj S, Borsi K, Jobbagy-Ovari G, Kallo K, Szekely AD, Fazekas A, Dobo-Nagy C, Sikiric P, Varga G.Antiinflammatory effect of BPC 157 on experimental periodontitis in rats. J Physiol Pharmacol. 2009;60 Suppl 7:115-122.
49. Hendriks T, Mastboom WJ. Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum. 1990;33:891-901. (Pubitemid 20350511)
50. Sikiric P, Jadrijevic S, Seiwerth S, Sosa T, Deskovic S, Perovic D, Aralica G, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Ziger T, Rotkvic I, Mise S, Zoricic I, Sebecic B, Patrlj L, Kocman B, Sarlija M, Mikus D, Separovic J, Hanzevacki M, Gjurasin M, Miklic P. Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats. J Physiol Paris. 1999;93:467-477. (Pubitemid 30038580)
51. Zoricic I, Sikiric P, Seiwerth S. Pentadecapeptide BPC 157 benefi cially influences the healing of colon-colon anastomoses in rats. In: Mozsik G, Nagy L, Par A, Rainsford KD, editors. Cell injury and protection in the gastrointestinal trace. From basic sciences to clinical perspectives 1996. Dordrecht Boston London: Kluwer Academic Publishers; 1997;249-258.
52. Pereira PM, Bines JE. New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome. J Gastroenterol Hepatol. 2006, 21: 932-940. (Pubitemid 43823275)
53. Kato Y, Yu D, Schwartz MZ. Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg. 1998;33:235-239. (Pubitemid 28093705)
54. Sigalet DL, Martin GR. Hormonal therapy for short bowel syndrome. J Pediatr Surg. 2000;35:360-364. (Pubitemid 30082601)
55. Lavery IC. Colonic fistulas. Surg Clin North Am. 1996;76:1183-1190. (Pubitemid 26315249)
56. Skorjanec S, Dolovski Z, Kocman I, Brcic L, Blagaic Boban A, Batelja L, Coric M, Sever M, Klicek R, Berkopic L, Radic B, Drmic D, Kolenc D, Ilic S, Cesarec V, Tonkic A, Zoricic I, Mise S, Staresinic M, Ivica M, Lovric Bencic M, Anic T, Seiwerth S, Sikiric P. Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole. Dig Dis Sci. 2009;54:46-56.
57. Blagaic AB, Blagaic V, Romic Z, Sikiric P. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Eur J Pharmacol. 2004;499:285-290. (Pubitemid 39233667)
58. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, Turkovic B, Jagic V, Mildner B, Duvnjak M. Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci. 1993;53:PL291-296.
59. Prkacin I, Separovic J, Aralicia G, Perovic D, Gjurasin M, Lovric-Bencic M, Stancic-Rokotov D, Staresinic M, Anic T, Mikus D, Sikiric P, Seiwerth S, Mise S, Rotkvic I, Jagic V, Rucman R, Petek M, Turkovic B, Marovic A, Sebecic B, Boban-Blagaic A, Kokic N. Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine.J Physiol Paris. 2001;95:315-324. (Pubitemid 33020256)
60. Prkacin I, Aralica G, Perovic D, Separovic J, Gjurasin M, Lovric-Bencic M, Stancic-Rokotov D, Ziger T, Anic T, Sikiric P, Seiwerth S, Staresinic M, Mise S, Rotkvic I, Jagic V, Rucman R, Petek M, Turkovic B, Marovic A, Sjekavica I, Sebecic B, Boban-Blagaic A, Ivasovic Z. Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats.J Physiol Paris. 2001;95:295-301. (Pubitemid 33020253)
61. Laziń R, Gabriń N, Dekaris I, Bosnar D, Boban-Blagaiń A, Sikiriń P. Gastric pentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats. Coll Antropol. 2005;29:321-325.
62. Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.Thromb Haemost. 2005;93:964-975. (Pubitemid 40691556)
63. Drucker DJ. Gut adaptation and the glucagon-like peptides. Gut 2002;50:428-435. (Pubitemid 34161064)
64. Radeljak S, Seiwerth S, Sikiric P. BPC 157 inhibits cell growth and VEGF signalling via the MAPK kinase pathway in the human melanoma cell line. Melanoma Res. 2004;14:A14-A15.